Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
51 - 60 out of 503Page size: 10
  1. 2023
  2. Published

    Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline

    the FIDELIO-DKD and FIGARO-DKD investigators, T. F. A. F. I., 2023, In: Diabetes, Obesity and Metabolism. 25, 6, p. 1512-1522 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trials

    Larsen, E. L., Andersen, A., Kjær, L. K., Eickhoff, M. K., Frimodt-Møller, M., Persson, F., Rossing, Peter, Lykkesfeldt, Jens, Knop, Filip Krag, Vilsbøll, Tina, Rungby, Jørgen & Poulsen, Henrik Enghusen, 2023, In: Free Radical Research. 57, 2, p. 140-151

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

    Beernink, J. M., Persson, F., Jongs, N., Laverman, G. D., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Diabetes Care. 46, 3, p. 602-607 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Endotrophin as a risk marker of mortality and kidney complications in a type 1 diabetes cohort

    Møller, A. L., Tougaard, N. H., Rasmussen, D. G. K., Genovese, F., Rønn, P. F., Hansen, T. W., Karsdal, M. A. & Rossing, Peter, 2023, In: Frontiers in Molecular Biosciences. 10, 1229579.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes

    Rossing, Peter, Groehl, F., Mernagh, P., Folkerts, K., Garreta-Rufas, A., Harris, J., Meredith, K., Carter, M., Åkerborg, Ö., Wanner, C. & Hobbs, F. D. R., 2023, In: Journal of Medical Economics. 26, 1, p. 935-943 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease

    Heinrich, N. S., Pedersen, R. P., Vestergaard, M. B., Lindberg, U., Andersen, U. B., Haddock, B., Hansen, T. W., Fornoni, A., Larsson, Henrik Bo Wiberg & Rossing, Peter, 2023, In: Diabetes, Obesity and Metabolism. 25, 9, p. 2605-2615 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis

    McEwan, P., Boyce, R., Sanchez, J. J. G., Sjöström, C. D., Stefansson, B., Nolan, S., Correa-Rotter, R., Rossing, Peter, Chertow, G. M., McMurray, J. J. V., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Nephrology Dialysis Transplantation. 38, 5, p. 1260-1270 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

    Filippatos, G., Anker, S. D., August, P., Coats, A. J. S., Januzzi, J. L., Mankovsky, B., Rossing, Peter, Ruilope, L. M., Pitt, B., Sarafidis, P., Teerlink, J. R., Kapelios, C. J., Gebel, M., Brinker, M., Joseph, A., Lage, A., Bakris, G. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 2, p. 183-191 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease

    Filippatos, G., Anker, S. D., Pitt, B., McGuire, D. K., Rossing, Peter, Ruilope, L. M., Butler, J., Jankowska, E. A., Michos, E. D., Farmakis, D., Farjat, A. E., Kolkhof, P., Scalise, A., Joseph, A., Bakris, G. L. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 1, p. 85-93 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

    Flack, J. M., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, Peter, Adler, S. G., Fried, L., Jamerson, K., Toto, R., Brinker, M., Farjat, A. E., Kolkhof, P., Lawatscheck, R., Joseph, A., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney Medicine. 5, 12, 11 p., 100730.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 7 8 9 ...51 Next

ID: 12937790